Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

rTMS in Older Adults With MCI and AUD

NCT: NCT05896332 · ACTIVE_NOT_RECRUITING

NCT IDNCT05896332
StatusACTIVE_NOT_RECRUITING
Start Date2023-11-01
Completion2026-06-30

Brief Summary

Alcohol misuse is a risk factor for early onset cognitive impairment, contributing to 10% of early onset dementia, with risk corresponding to consumption. Additionally, continued drinking risks worsening cognitive decline and dementia progression, while worsening cognitive impairment contributes to drinking escalation. Repetitive transcranial magnetic stimulation (rTMS) has been shown to improve cognition in Alzheimer's Disease and Related Dimentias (ADRD) and separately reduce heavy drinking in alcohol use disorder. Our objective is to optimize rTMS for simultaneous mitigation of both drinking and cognitive dysfunction in older adults.

Frequently Asked Questions

What is rTMS in Older Adults With MCI and AUD?

rTMS in Older Adults With MCI and AUD is a clinical trial registered under NCT05896332. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05896332?

The current status of NCT05896332 (rTMS in Older Adults With MCI and AUD) is: ACTIVE_NOT_RECRUITING.

When did rTMS in Older Adults With MCI and AUD start?

rTMS in Older Adults With MCI and AUD started on 2023-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.